Serum lactates correlate with mortality after operations for complex congenital heart disease

I M Cheifetz1, F H Kern, S R Schulman

  • 1Department of Pediatrics, Duke Children's Hospital, Duke University Medical Center, Durham, North Carolina 27710, USA. cheif002@mc.duke.edu

Insights

Serum lactate levels can predict mortality in infants after heart surgery. Higher lactate levels post-cardiopulmonary bypass indicate increased risk in children with congenital heart disease.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Biomarkers in Medicine

Background:

  • Complex congenital heart disease necessitates cardiopulmonary bypass in infants.
  • Assessing post-operative outcomes in this vulnerable population is crucial.
  • Predictive markers for mortality are needed for early intervention.

Purpose of the Study:

  • To investigate serum lactate levels as a predictor of mortality.
  • To evaluate lactate levels in infants undergoing cardiopulmonary bypass for congenital heart disease.

Main Methods:

  • Analysis of initial, maximum, and 4-6 hour post-operative lactate levels.
  • Study included 48 infants (<1 year) undergoing cardiopulmonary bypass.
  • Comparison of lactate levels between survivors and non-survivors.

Main Results:

  • Significantly higher lactate levels (initial, max, 4-6h) in non-survivors compared to survivors.
  • Specific lactate thresholds (initial <7, max <9, 4-6h <4 mmol/L) were associated with survival.
  • Lactate levels demonstrated a clear correlation with mortality risk.

Conclusions:

  • Serum lactate levels show potential as a predictive biomarker for mortality in infants post-cardiopulmonary bypass.
  • Elevated lactate post-complex congenital heart surgery warrants close monitoring for potential mortality.
  • Lactate monitoring can aid in risk stratification and clinical decision-making.
Abstract